NYSE : BMY
$0.58 (0.94%)
2.70%
802
change: -1824 | last: 2626361
change: -971 | last: 1332310
change: -570 | last: 88043
change: -230 | last: 2731787
change: 1594 | last: 1933800
8600
2.26
change: 133.1559 | last: 0.93163.15B
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-04-29 | Vanguard Capital Management | 153.11M | 7.49% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2025-10-31 | JPMORGAN CHASE & CO. | 81.89M | 4.00% |
| 2025-04-25 | JPMORGAN CHASE & CO. | 104.69M | 5.10% |
| 2025-04-17 | BlackRock, Inc. | 143.57M | 7.10% |
| 2025-02-14 | BRISTOL MYERS SQUIBB CO | 426.37K | 1.90% |
| 2025-02-14 | BRISTOL MYERS SQUIBB CO | 200.24K | 1.64% |
| 2025-02-14 | BRISTOL MYERS SQUIBB CO | 1.84M | 2.06% |
| 2024-11-13 | Bristol-Myers Squibb Company | 759.14K | 6.23% |
| 2024-10-04 | Bristol-Myers Squibb Company | 11.01M | 8.40% |
| 2023-12-04 | Bristol-Myers Squibb Company | 5.08M | 6.40% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 199.83M | 9.00% |
| 2022-02-01 | (1) BlackRock, Inc. | 169.23M | 7.60% |
| 2021-11-19 | BRISTOL-MYERS SQUIBB COMPANY | 4.76M | 5.50% |
| 2021-07-26 | BRISTOL-MYERS SQUIBB COMPANY 22-0790350 | 11.95M | 9.90% |
| 2021-07-26 | CELGENE CORPORATION 22-2711928 | 11.95M | 9.90% |
| 2021-04-05 | CELGENE CORPORATION 22-2711928 | 1.73M | 3.80% |
| 2021-04-05 | CELGENE CORPORATION 22-2711928 | 2.13M | 5.90% |
| 2021-04-05 | CELGENE CORPORATION 22-2711928 | 1.63M | 5.10% |
| 2021-04-05 | BRISTOL-MYERS SQUIBB COMPANY 22-0790350 | 1.73M | 3.80% |
| 2021-04-05 | BRISTOL-MYERS SQUIBB COMPANY 22-0790350 | 3.46M | 7.60% |
| 2021-04-05 | BRISTOL-MYERS SQUIBB COMPANY 22-0790350 | 1.63M | 5.10% |
| 2021-04-05 | BRISTOL-MYERS SQUIBB COMPANY 22-0790350 | 2.13M | 5.90% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 199.34M | 8.82% |
| 2021-01-29 | (1) BlackRock, Inc. | 172.46M | 7.60% |
| 2020-02-12 | The Vanguard Group - 23-1945930 | 194.86M | 8.32% |
| 2020-02-05 | (1) BlackRock, Inc. | 171.34M | 7.30% |
| 2020-01-28 | Wellington Investment Advisors Holdings LLP | 83.47M | 3.57% |
| 2020-01-28 | Wellington Group Holdings LLP | 83.47M | 3.57% |
| 2020-01-28 | Wellington Management Group LLP | 83.47M | 3.57% |
| 2019-05-10 | Wellington Management Group LLP | 121.15M | 7.41% |
| 2019-05-10 | Wellington Group Holdings LLP | 121.15M | 7.41% |
| 2019-05-10 | Wellington Management Company LLP | 113.64M | 6.95% |
| 2019-05-10 | Wellington Investment Advisors Holdings LLP | 121.15M | 7.41% |
| 2019-02-27 | Wellington Group Holdings LLP | 60900.0 | 7.70% |
| 2019-02-27 | Wellington Management Company LLP | 60900.0 | 7.20% |
| 2019-02-27 | Wellington Management Group LLP | 60900.0 | 7.70% |
| 2019-02-27 | Wellington Investment Advisors Holdings LLP | 60900.0 | 7.70% |
| 2019-02-12 | Wellington Investment Advisors Holdings LLP | 136.6M | 8.37% |
| 2019-02-12 | Wellington Management Company LLP | 125.97M | 7.72% |
| 2019-02-12 | Wellington Management Group LLP | 136.6M | 8.37% |
| 2019-02-12 | Wellington Group Holdings LLP | 136.6M | 8.37% |
| 2019-02-04 | (1) BlackRock, Inc. | 115.57M | 7.10% |
| 2018-02-08 | (1) BlackRock, Inc. | 104.29M | 6.40% |
| 2018-02-08 | Wellington Group Holdings LLP | 138.08M | 8.44% |
| 2018-02-08 | Wellington Investment Advisors Holdings LLP | 138.08M | 8.44% |
| 2018-02-08 | Wellington Management Company LLP | 129.45M | 7.91% |
| 2018-02-08 | Wellington Management Group LLP | 138.08M | 8.44% |
| 2017-02-09 | Wellington Investment Advisors Holdings LLP | 148.24M | 8.87% |
| 2017-02-09 | Wellington Group Holdings LLP | 148.24M | 8.87% |
| 2017-02-09 | Wellington Management Company LLP | 138.24M | 8.27% |
| 2017-02-09 | Wellington Management Group LLP | 148.24M | 8.87% |
| 2017-01-19 | (1) BlackRock, Inc. | 99.7M | 6.00% |
| 2016-02-11 | Wellington Group Holdings LLP | 137.7M | 8.25% |
| 2016-02-11 | Wellington Investment Advisors Holdings LLP | 137.7M | 8.25% |
| 2016-02-11 | Wellington Management Company LLP | 126.77M | 7.60% |
| 2016-02-11 | Wellington Management Group LLP | 137.7M | 8.25% |
| 2016-02-10 | (1) BlackRock, Inc. | 103.95M | 6.20% |
| 2015-08-17 | 22-0790350 | 2.39M | 9.90% |
| 2015-06-22 | 22-0790350 | 1.11M | 4.90% |
| 2015-02-13 | 13G | - | 0.00% |
| 2015-02-13 | 13G | 1.3M | 4.14% |
| 2015-02-09 | (1) BlackRock, Inc. | 109.11M | 6.60% |
| 2014-10-06 | 13G | 1.3M | 10.00% |
| 2014-05-19 | 22-0790350 | 1.6M | 5.35% |
| 2014-02-10 | (1) BlackRock, Inc. | 105.18M | 6.40% |
| 2013-02-06 | (1) BlackRock, Inc. | 112.48M | 6.81% |
| 2012-02-13 | (1) BlackRock, Inc. | 113.14M | 6.68% |
| 2012-01-13 | Inta Acquisition Corporation | 11.37M | 14.00% |
| 2012-01-13 | 22-0790350 | 11.37M | 14.00% |
| 2011-02-03 | (1) BlackRock, Inc. | 133.82M | 7.82% |
| 2010-02-12 | 22-0790350 | 1.28M | 3.70% |
| 2010-01-29 | BlackRock for purposes of Schedule 13G filings. | 135.56M | 7.92% |
| 2009-12-09 | Medarex, Inc. | 2.47M | 7.83% |
| 2009-12-09 | Bristol-Myers Squibb Company | 2.47M | 7.83% |
| 2009-02-27 | 22-0790350 | 42.34M | 55.10% |
| 2008-10-08 | 22-3828046 | 14.39M | 16.60% |
| 2008-10-08 | 22-0790350 | 14.39M | 16.60% |
| 2008-07-31 | 22-0790350 | 14.39M | 16.60% |
| 2008-07-31 | 22-3828046 | 14.39M | 16.60% |
| 2006-02-14 | 22-079-0350 | 519.75K | 2.70% |
| 2006-02-01 | 22-0790350 | 14.39M | 17.10% |
| 2006-02-01 | 22-3828046 | 14.39M | 17.10% |
| 2005-02-14 | 22-079-0350 | 1.17M | 2.95% |
| 2005-02-14 | 22-079-0350 | 2.08M | 7.40% |
| 2003-04-03 | (. | 847.48K | 2.10% |
| 2003-02-13 | Edward C. Johnson 3d | 61.59M | 3.18% |
| 2003-02-13 | FMR Corp. | 61.59M | 3.18% |
| 2003-02-13 | Abigail P. Johnson | 61.59M | 3.18% |
| 2002-02-21 | BRISTOL-MYERS SQUIBB COMPANY | 2.65M | 7.60% |
| 2002-02-13 | FMR Corp. | 122.01M | 6.31% |
| 2002-02-13 | Edward C. Johnson 3d | 122.01M | 6.31% |
| 2002-02-13 | Abigail P. Johnson | 122.01M | 6.31% |
| 2001-02-13 | Edward C. Johnson 3d | 120.73M | 6.17% |
| 2001-02-13 | Abigail P. Johnson | 120.73M | 6.17% |
| 2001-02-13 | FMR Corp. | 120.73M | 6.17% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $53.94 | 2.04B | $110.09B | $10.21B | $47.14B | $147.02B |
| 2024-12-31 | $56.56 | 2.03B | $114.65B | $10.35B | $51.2B | $155.5B |
| 2023-12-31 | $51.31 | 2.07B | $106.16B | $11.46B | $41.46B | $136.16B |
| 2022-12-31 | $71.95 | 2.13B | $153.25B | $9.12B | $40.72B | $184.85B |
| 2021-12-31 | $62.35 | 2.22B | $138.48B | $13.98B | $45.6B | $170.1B |
| 2020-12-31 | $62.03 | 2.26B | $140.06B | $14.55B | $51.67B | $177.19B |
| 2019-12-31 | $64.19 | 1.7B | $109.44B | $12.35B | $47.54B | $144.64B |
| 2018-12-31 | $51.98 | 1.63B | $84.88B | $6.91B | $7.35B | $85.32B |
| 2017-12-31 | $61.28 | 1.64B | $100.81B | $5.42B | $7.96B | $103.35B |
| 2016-12-31 | $58.44 | 1.67B | $97.65B | $4.24B | $6.71B | $100.12B |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60.65 | 2.04B | $123.94B | $9.57B | $44.46B | $158.82B |
| 2025-12-31 | $53.94 | 2.04B | $110.09B | $10.21B | $47.14B | $147.02B |
| 2025-09-30 | $45.10 | 2.04B | $91.91B | $15.73B | $51.04B | $127.23B |
| 2025-06-30 | $46.29 | 2.04B | $94.2B | $12.6B | $50.93B | $132.53B |
| 2025-03-31 | $60.99 | 2.03B | $123.87B | $10.88B | $51.24B | $164.23B |
| 2024-12-31 | $56.56 | 2.03B | $114.76B | $10.35B | $51.2B | $155.62B |
| 2024-09-30 | $51.74 | 2.03B | $104.93B | $7.89B | $51.4B | $148.44B |
| 2024-06-30 | $41.30 | 2.03B | $83.72B | $6.29B | $54B | $131.43B |
| 2024-03-31 | $52.99 | 2.02B | $107.2B | $9.33B | $57.41B | $155.28B |
| 2023-12-31 | $51.31 | 2.03B | $104.01B | $11.46B | $41.46B | $134.01B |
| 2023-09-30 | $58.04 | 2.06B | $119.39B | $7.51B | $39.27B | $151.14B |
| 2023-06-30 | $63.95 | 2.09B | $133.85B | $8.37B | $39.19B | $164.66B |